@inproceedings{inproceedings, title  = {{Safety of Amlitelimab in a Phase 2a Clinical Trial of Patients With Moderate-to-Severe Atopic Dermatitis}},

 url = {{}},

 year = {{2023}},

 month = {{1}},

 author = {{Weidinger S and Cork M and Reich A and Bieber T and Gilbert S and Quaratino S and Wilson R and Porter-Brown B}},

 volume = {{89}},

 journal = {{JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY}},

 issue = {{3}},

 pages = {{AB221-AB221}},

 note = {{Accessed on 2024/12/22}}}